Results 41 to 50 of about 112,825,263 (146)

Lymphatic blood filling in CLEC-2-deficient mouse models

open access: yes, 2020
C-type lectin-like receptor 2 (CLEC-2) is considered as a potential drug target in settings of wound healing, inflammation, and infection. A potential barrier to this is evidence that CLEC-2 and its ligand podoplanin play a critical role in preventing ...
Babak J Mehrara (8530731)   +13 more
core   +1 more source

CLEC‐2 is not required for platelet aggregation at arteriolar shear [PDF]

open access: yesJournal of Thrombosis and Haemostasis, 2010
The C-type lectin receptor CLEC-2 is expressed primarily on the surface of platelets, where it is present as a dimer, and is found at low level on a subpopulation of other hematopoietic cells, including mouse neutrophils [1–4] Clustering of CLEC-2 by the snake venom toxin rhodocytin, specific antibodies or its endogenous ligand, podoplanin, elicits ...
Craig E, Hughes   +5 more
openaire   +2 more sources

The novel platelet activation receptor CLEC-2

open access: yesPlatelets, 2011
The c-type lectin-like receptor 2 (CLEC-2) was first identified from a bio-informatic screen for c-type lectin-like receptors. However, neither its function nor its ligand(s) had been elucidated for several years. In 2006, we reported that the receptor is expressed on the surface of platelets and serves as a receptor for the snake venom rhodocytin ...
Katsue, Suzuki-Inoue   +2 more
openaire   +2 more sources

CLEC-2 is required for development and maintenance of lymph nodes [PDF]

open access: yesBlood, 2014
Key Points CLEC-2 is necessary for lymphatic cell proliferation and lymph node anlage persistence after birth. Lack of CLEC-2 expression on megakaryocytes and platelets compromises lymph node integrity in adult life.
Cécile, Bénézech   +10 more
openaire   +2 more sources

Low-dose Btk inhibitors selectively block platelet activation by CLEC-2

open access: yesHaematologica, 2020
Inhibitors of the tyrosine kinase Btk have been proposed as novel antiplatelet agents. In this study we show that low concentrations of the Btk inhibitor ibrutinib block CLEC-2-mediated activation and tyrosine phosphorylation including Syk and PLCγ2 in ...
Phillip L.R. Nicolson   +19 more
doaj   +1 more source

CLEC-2 Supports Platelet Aggregation in Mouse but not Human Blood at Arterial Shear [PDF]

open access: yes, 2022
C-type lectin-like receptor 2 (CLEC-2) is highly expressed on platelets and a subpopulation of myeloid cells, and is critical in lymphatic development.
Thomas, Mark R.   +35 more
core   +1 more source

The Platelet Receptor CLEC-2 Is Active as a Dimer

open access: yesBiochemistry, 2009
The platelet receptor CLEC-2 binds to the snake venom toxin rhodocytin and the tumor cell surface protein podoplanin. Binding of either of these ligands promotes phosphorylation of a single tyrosine residue in the YXXL motif in the intracellular domain of CLEC-2.
Watson, A.   +9 more
openaire   +3 more sources

Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2

open access: yesRetrovirology, 2010
Background Platelets are associated with HIV in the blood of infected individuals and might modulate viral dissemination, particularly if the virus is directly transmitted into the bloodstream.
Münch Jan   +10 more
doaj   +1 more source

Binding of Fc-CLEC-2 to podoplanin in pod-HeLa cell lysates.

open access: yes, 2019
(A) Effect of prior reduction of Fc-CLEC-2 disulfide bonds with DTT on its binding to podoplanin. Purified Fc-CLEC-2 in PBS was untreated or treated with 10 mM DTT for 5 h at room temperature.
Yusuke Suzuki (525707)   +10 more
core   +1 more source

Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases

open access: yesPlatelets, 2021
Antiplatelet medications comprise the cornerstone of treatment for diseases that involve arterial thrombosis, including acute coronary syndromes (ACS), stroke and peripheral arterial disease.
Maan H. Harbi   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy